FDA Inspection 1292364 — Merle Norman Cosmetics, Inc.

Merle Norman Cosmetics, Inc. — FEI 2013383

The FDA completed an inspection of Merle Norman Cosmetics, Inc. on November 21, 2025 in Los Angeles, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 21, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Los Angeles, CA (United States)

Citations

IDCFRDescription
113321 CFR 211.25(a)GMP Training Frequency
121521 CFR 211.67(b)Written procedures not established/followed
180121 CFR 211.84(a)Components withheld from use pending release
184421 CFR 211.84(d)(2)Establish reliability of supplier's C of A
357121 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
359221 CFR 211.110(c)In-process materials characteristics testing
457621 CFR 211.192No written record of investigation